We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$71M
AUM Growth
+$26.4M
Cap. Flow
+$24M
Cap. Flow %
33.85%
Top 10 Hldgs %
86.77%
Holding
60
New
18
Increased
1
Reduced
6
Closed
24

Top Buys

Rank Stock Value
1
ABEO icon
Abeona Therapeutics
ABEO
+$14.8M
2
AMRS
Amyris Inc.
AMRS
+$7.71M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$6.36M
4
REPL icon
Replimune Group
REPL
+$5.92M
5
HEXO
HEXO Corp. Common Shares
HEXO
+$5.48M

Top Sells

Rank Stock Value
1
CARM
Carisma Therapeutics
CARM
+$5.54M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$2.59M
3
VUZI icon
Vuzix
VUZI
+$1.52M
4
EMWP
Eros Media World PLC
EMWP
+$1.5M
5
CRMD icon
CorMedix
CRMD
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 66.73%
2 Materials 11.48%
3 Industrials 0.19%
4 Consumer Staples 0.16%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
1
Abeona Therapeutics
ABEO
$355M
$17.1M 24.08%
+209,095
New +$14.8M
AMRS
2
DELISTED
Amyris Inc.
AMRS
$6.43M 9.05%
+2,079,661
New +$7.71M
REPL icon
3
Replimune Group
REPL
$455M
$5.89M 8.3%
+410,528
New +$5.92M
MNKD icon
4
MannKind Corp
MNKD
$1.19B
$4.78M 6.73%
+3,705,310
New +$4.74M
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.58M 6.45%
+13,868
New +$6.36M
HEXO
6
DELISTED
HEXO Corp. Common Shares
HEXO
$3.7M 5.22%
+41,586
New +$5.48M
XCUR icon
7
Exicure
XCUR
$11M
$3.47M 4.89%
8,095
-408
-5% -$167K
MCF
8
DELISTED
Contango Oil & Gas Co.
MCF
$2.57M 3.62%
+700,000
New +$2.06M
FLNA
9
Filana Therapeutics
FLNA
$42M
$2.35M 3.31%
+452,246
New +$781K
NAK
10
Northern Dynasty Minerals
NAK
$773M
$1.4M 1.98%
+3,280,759
New +$1.72M
BCEL
11
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.28M 1.81%
+83,001
New +$1M
SVRA icon
12
Savara
SVRA
$1.08B
$917K 1.29%
+204,666
New +$246K
NTBL
13
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$801K 1.13%
19,079
-4,467
-19% -$193K
ACHV icon
14
Achieve Life Sciences
ACHV
$634M
$620K 0.87%
+58,497
New +$1.25M
SCYX icon
15
SCYNEXIS
SCYX
$37.4M
$586K 0.83%
+8,046
New +$664K
BCRX icon
16
BioCryst Pharmaceuticals
BCRX
$2.42B
$514K 0.72%
+148,952
New +$375K
RGLS
17
DELISTED
Regulus Therapeutics
RGLS
$344K 0.48%
+38,597
New +$268K
AMPE
18
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$324K 0.46%
+1,855
New +$240K
AUMN
19
DELISTED
Golden Minerals Company
AUMN
$317K 0.45%
40,850
-30,427
-43% -$189K
BVXVW
20
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$189K 0.27%
72,800
– –
AEHL icon
21
Antelope Enterprise Holdings
AEHL
$9.28M
$136K 0.19%
+28
New +$152K
FAMI icon
22
Farmmi Inc
FAMI
$5.61M
$117K 0.16%
65
+29
+81% +$92.5K
VERBW
23
DELISTED
Verb Technology Company, Inc. Warrant
VERBW
$108K 0.15%
240,000
– –
LPCN icon
24
Lipocine
LPCN
$17.1M
$105K 0.15%
+16,027
New +$410K
FPAYW
25
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$58K 0.08%
38,443
-11,557
-23% -$9.09K
1
2 3

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q4 2019 Portfolio in Review

As of Q4 2019, CVI Holdings held 60 positions worth $71M, up 59% from $44.5M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

CVI Holdings deployed $24M of net new capital in Q4 2019, opening 18 new positions and adding to 1 existing holding. Its largest new stake was Abeona Therapeutics: 209,095 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 39% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Notable Labs, Ltd. Ordinary Shares, an estimated $193K trimmed.

  • CVI Holdings's largest Q4 2019 buy was Abeona Therapeutics: 209,095 shares worth $17.1M.
  • CVI Holdings added most to Farmmi Inc in Q4 2019, an estimated $92.5K increase.
  • CVI Holdings's biggest Q4 2019 reduction was Notable Labs, Ltd. Ordinary Shares, cutting an estimated $193K.
  • CVI Holdings fully exited Carisma Therapeutics in Q4 2019, selling an estimated $5.54M.
  • CVI Holdings's ten largest holdings make up 87% of its $71M portfolio in Q4 2019.
  • CVI Holdings opened 18 new positions and closed 24 in Q4 2019.
  • CVI Holdings's portfolio value rose 59% quarter-over-quarter to $71M.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.